PONUMKIBART
UNII LC6T7422LW

Substance Identification & Data

This profile provides standardized clinical and technical data for Ponumkibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LC6T7422LW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3035680-82-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LC6T7422LW

CAS Registry Number

3035680-82-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PONUMKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C224778

National Cancer Institute reference terminology for clinical and research data.

INN ID

13641

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ponumkibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PONUMKIBART

Common Names & Synonyms

H-GAMMA4 HEAVY CHAIN HUMANIZED (1-445) (VH (HOMO SAPIENS IGHV1-2*06 (85.7%) -(IGHD) -IGHJ6*01 (90.9%) T123>L (113), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, 12-G4V5 H P10 (CH1 (119-216), HINGE 1-12 S10>P (226) (217-228), CH2 L92 (307) (229-338), CH3 (339-443), CHS (444-445)) (119-445)), (132-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-12*01 (84.4%) -IGKJ4*01 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN INTERLEUKIN 17 RECEPTOR B) (HUMAN-MUS MUSCULUS MONOCLONAL SM-C151 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SM-C151 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS IL17RB (INTERLEUKIN 17 RECEPTOR B)), HUMANIZED MONOCLONAL ANTIBODY (PONUMKIBART)

PONUMKIBART [INN]

External Clinical & Regulatory Resources

Previous UNIILC6FVP3Q94

Next UNIILC6T8F3LPW